Yaodou Network Secures Hundreds of Millions in Series C Funding Led by Morgan Stanley

VCBeat (WeChat: Vcbeat) has learned that Yao Dou Wang, a well-known domestic internet pharmaceutical company, recently completed a C-round financing of hundreds of millions of yuan. This round was led by Morgan Stanley, with existing shareholder Nanxi Venture Capital continuing to increase its investment.

This round of financing will be primarily used to enhance staffing, optimize the layout of central and forward warehouses, strengthen warehousing and distribution capabilities within the supply chain system, and further improve the S2B2C sales network. In addition to continuously refining its nationwide business layout, Yao Dou Wang is also strengthening its technological capability framework and its service coverage for small and medium-sized terminals.

Yao Dou Wang is a technology platform providing comprehensive internet-based pharmaceutical services. With a deep focus on the out-of-hospital pharmaceutical market, it boasts diversified strengths in areas such as market access, pharmaceutical distribution, cross-border e-commerce, and bonded imports. By leveraging its “Two Networks, One Warehouse, One Store” business model, the company has built an efficient online supply chain system and a nationwide sales network. Committed to becoming China’s leading smart pharmaceutical service and retail platform integrating “healthcare, pharmaceuticals, and insurance,” Yao Dou Wang aims to provide Chinese citizens with more convenient and affordable medication and health services.

Following this round of financing, Yao Dou Wang will continue to deepen its internet-based distribution business, enhance the platform’s digital capabilities, empower the entire pharmaceutical industry chain with technology, strengthen its core competitive advantages in the field of online pharmaceutical distribution, and build a closed-loop “medical care + pharmaceuticals + insurance” ecosystem.